`

Tagged: FDA

BioCentury – FDA may crack down on clinical trial reporting

September 24th, 2018 | FDA

We have recently seen an abundance of proposed changes to the process of how Sponsor companies interact with and report to the FDA, and this new idea is no different. Having a flexible and adaptable staff is the key to future success in our industry as it continues to grow and change. FDA is signaling […]

FDA decision looming, Alnylam plans to double staff, triple Kendall Square footprint – Boston Business Journal

August 7th, 2018 | FDA

Pin It on Pinterest